-
Signature
-
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
-
Issuer symbol
-
APUS
-
Transactions as of
-
12 May 2024
-
Net transactions value
-
$0
-
Form type
-
4/A - Amendment
-
Filing time
-
21 Nov 2025, 21:26:11 UTC
-
Date Of Original Report
-
14 May 2025
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Inscobee Inc. |
10%+ Owner |
ROOM 613, DIGITAL-RO 130, 6F, GEUMCHEON-GU, SEOUL, KOREA, REPUBLIC OF |
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact |
21 Nov 2025 |
0002057997 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| holding |
APUS |
Common Stock, par value $0.0001 per share |
|
|
|
|
|
4,316,618 |
12 May 2024 |
By Apimeds Inc. |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
On May 14, 2025, the reporting person filed a Form 4 (the "Form 4"), which incorrectly reported that the reporting person had indirect beneficial ownership of a Convertible Promissory Note in the amount of $184,833 (the "Note") and the shares of common stock underlying such Note (the "Shares"), through Apimeds Korea. On June 11, 2025, the reporting person filed an amendment to the Form 4 (the "Original Amendment"), to report that the reporting person directly owned the Note and the Shares. The Original Amendment did not update the holdings of Apimeds Korea to reflect that the Note and the Shares were directly owned by the reporting person. This amendment is being filed solely to correct Apimeds Korea's reported holdings. For the avoidance of doubt, as of May 12, 2025, the reporting person had direct beneficial ownership of 2,099,747 shares of common stock and indirect beneficial ownership of 4,316,618 shares of common stock held by Apimeds Korea.